INM - שולי רווח נקי inmedpharma.com

InMed Pharmaceuticals Inc (INM) - לוגו תאגידי

InMed Pharmaceuticals (INM) is struggling against pressure from traditional painkillers and legal barriers. The net margin dynamics on the GURU.Markets chart confirm this, with the current value standing at -1657.70. A strategic alliance with clinics to develop rare molecules enhances its investment appeal, although a narrow specialization in biosynthesis makes business success dependent on patent rulings.

InMed (INM) - שיעור רווח נקי מ-04.07.2022 עד 09.11.2026

InMed (INM) - פילוחי מדדים ודוחות פיננסיים

- מחיר מניה וקונצנזוס הערכת שווי:
ניתוח בסיסי של החברה:inmedpharma.com - INM
מוצר המיוצר על ידי InMed Pharma

Sales margins measure the share of net profit in every dollar of revenue, determining overall operational efficiency. This ratio allows an investor to assess the business's resilience to rising costs. An analysis of the net margin of core operations reveals critical profitability dips in real time. For InMed Pharmaceuticals (INM), this is critical, as sanction risks in raw material supplies directly impact profitability.